US Patent 8987233 Bruton's tyrosine kinase activity probe and method of using
Patent 8987233 was granted and assigned to Pharmacyclics on March, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+182 characters)
Article
Patent abstract
Described herein are probes for Bruton's tyrosine kinase (Btk). Such probes are used to characterize and develop Btk-selective inhibitors intended for therapeutic use.
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Erik Verner0
Heleen Scheerens0
Lee Honigberg0
Shyr Jiann Li0
Zhengying Pan0
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08987233 Bruton's tyrosine kinase activity probe and method of using US Patent 8987233 Bruton's tyrosine kinase activity probe and method of using
Infobox
Patent Number
089872330
Patent Number
89872330
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
089872330
Date of Patent
March 24, 2015
0Patent Application Number
119352770
Date Filed
November 5, 2007
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 29 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08987233 Bruton's tyrosine kinase activity probe and method of using
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08987233
Date of patent
March 24, 2015
Patent application number
11935277
Date Filed
November 5, 2007
Patent primary examiner
Find more entities like US Patent 8987233 Bruton's tyrosine kinase activity probe and method of using
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
